Amgen Inc. (AMGN)
$443.84+1.03%Close
BUYBULL · day 23
Key stats
Short interest · FINRA settlement 2026-07-31
52-week IV13.5%–55.4%
- Market cap
- $239.5B
- Avg volume
- 2.7M
- Beta
- 0.41
- Div yield
- 2.24%
- P/E (TTM)
- 27.36
- IV-%ile
- 88
- IV ATM
- 35.8%
- Short % float
- 2.47%
- Days to cover
- 5.2
- SI change
- +3.4%
- 1W
- +5.83%
- 1M
- +18.03%
- 3M
- +30.81%
- YTD
- +35.47%
- vs SPY 1W
- +7.02%
- vs SPY 1M
- +14.71%
- vs SPY 3M
- +28.42%
- vs SPY YTD
- +23.71%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- UTMDBUYUtah Medical Products, Inc.BULLQ 9$71.62+0.10%
- HLNBUYHaleon plcBULLQ 19$10.16+1.60%
- GDRXBUYGoodRx Holdings, Inc.RECOVERYQ -18$3.44-0.29%
- UFPTBUYUFP Technologies, Inc.BULLQ 23$305.39-1.21%
- UNHSELLUnitedHealth Group IncorporatedBEARQ 16$398.76+2.22%
- EWBUYEdwards Lifesciences CorporationBULLQ 19$90.50+0.79%
- WSTSELLWest Pharmaceutical Services, Inc.BULLQ 18$353.32+0.07%
- TBPHBUYTheravance Biopharma, Inc.BULLQ -1$17.01+0.00%
- KNSABUYKiniksa Pharmaceuticals, Ltd.BULLQ 23$79.38+0.44%
- LQDASELLLiquidia CorporationCRISISQ 24$70.27+2.40%
- AGENBUYAgenus Inc.RECOVERYQ -1$7.67-5.19%
- MDXGBUYMiMedx Group, Inc.RECOVERYQ 7$4.27-1.39%
Industry peers
FMP comparable companies · ranked by market cap
- MRKBUYMerck & Co., Inc.$372.2BBULLQ 7$150.69-1.22%
- NVSBUYNovartis AG$300.4BBULLQ 16$158.02-0.53%
- NVOSELLNovo Nordisk A/S$208.4BRECOVERYQ 19$46.93+0.39%
- GILDBUYGilead Sciences, Inc.$182.2BRECOVERYQ 23$146.74+0.42%
- PFEBUYPfizer Inc.$159.4BBULLQ 8$27.97-0.36%
- DHRBUYDanaher Corporation$151.3BRECOVERYQ 26$215.20-1.71%
- BMYBUYBristol-Myers Squibb Company$137.4BBULLQ 6$67.28+0.40%
- SNYBUYSanofi$109.7BRECOVERYQ 6$45.69-0.35%
- GSKBUYGSK plc$103.7BRECOVERYQ 6$51.78-1.11%
- BSXBUYBoston Scientific Corporation$72.8BRECOVERYQ 7$49.01-2.70%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 29
- VALUE
- 25
- GROWTH
- 52
- GARP
- 8
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC53.6%
REV YoY-
ROE89.3%
EPS YoY-
ROA9.1%
GROSS73
OP33
NET23
[VALUATION]
P/E TTM27.36
P/E FWD-
SECTOR PE22.66
INDUSTRY PE11.13
P/B20.51
P/FCF-
EV/EBITDA17.13
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E490.28
ALTMAN Z-
CURR RATIO1.37
ND/EBITDA-
BETA0.41
